Objective: To determine the clinical value of compound Xueshuantong capsule in the treatment of diabetic retinopathy on the basis of laser treatment. Methods: Data were collected from 98 patients with diabetic retinopathy from February 2021 to February 2022. They were divided into two groups by drawing lots. The experimental group was treated with compound Xueshuantong capsule and laser treatment, whereas the control group was treated with laser treatment alone. Results: The absorption of exudation, resolution of retinal edema, and absorption of bleeding took longer in the control group; the incidence of visual acuity recovery to more than 0.5 and the patients’ blood glucose levels were better in the experimental group, p < 0.05. Conclusion: For patients with diabetic retinopathy, laser treatment combined with compound Xueshuantong capsule can effectively improve the visual function and rehabilitation efficiency of patients with diabetic retinopathy as well as stabilize their blood sugar levels. It has high clinical application value.
Han L, 2021, Efficacy Evaluation of Compound Xueshuantong Capsule Combined with Calcium Oxybenzenesulfonic Acid in the Treatment of Patients with Early Diabetic Retinopathy. Heilongjiang Medicine and Pharmacy, 44(06): 135-137.
Yu P, 2019, Clinical Effect of Calcium Dobesilate Capsules Combined with Fundus Laser in the Nonproliferative Treatment of Diabetic Retinopathy. Chinese Journal of Modern Drug Application, 13(14): 127-128.
Song Z, Li C, 2019, Effect of Laser Photocoagulation Combined with Compound Xueshuantong Capsule on Diabetic Retinopathy Combined with Macular Edema. Laboratory Medicine and Clinic, 16(22): 3276-3279.
Lin J, 2019, Clinical Effect Evaluation of Fundus Laser Combined with Compound Xueshuantong Capsule in the Treatment of Diabetic Retinopathy. Diabetes New World, 22(18): 180-182.